-
Study aim
-
Determining the effect of Shirazi thyme essential oil on the clinical symptoms of patients with gastroesophageal reflux
-
Design
-
A clinical trial with a control group, with parallel groups, without blinding, randomization, phase 3, on 70 patients, was used to randomize the table of random numbers.
-
Settings and conduct
-
The present study is a two-group randomized clinical trial. The patients with gastroesophageal reflux referring to Allameh Bahloul Gonabadi Hospital, Gonabad City, are the studied community. After obtaining informed consent, the demographic questionnaire and the reflux disease questionnaire will be distributed among the samples and completed by them. In the control group, no intervention is performed for the patients, and for these patients, educational and therapeutic measures are performed normally. In the intervention group, two gastrolith capsules containing Shirazi thyme essential oil are given to the patients after lunch and dinner for 6 weeks. After the end of the study, the patients will complete the reflux disease questionnaire again and finally the collected data will be analyzed using SPSS version 22 software.
-
Participants/Inclusion and exclusion criteria
-
Inclusion criteria: patients between 20 and 60 years old with second-degree gastroesophageal reflux disease who were unable to resolve the symptoms with lifestyle changes. And they did not have gastrointestinal bleeding or surgery during the study.
Exclusion criteria: patients who do not want to participate in the study or are admitted to the hospital during the study.
-
Intervention groups
-
In the control group, no intervention is performed and these patients receive training and treatment as usual.
In the intervention group, one gastrolith capsule containing Shirazi thyme essential oil was given to the patients daily for 6 weeks after lunch and dinner.
-
Main outcome variables
-
Severity of gastroesophageal reflux